Kyoto, Japan

Toshikazu Bando

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Tokyo, JP (2005 - 2008)
  • Kyoto, JP (2010 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Toshikazu Bando

Introduction

Toshikazu Bando is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel alkylating agents and gene expression control agents. With a total of 7 patents to his name, Bando's work has the potential to impact cancer treatment and stem cell research.

Latest Patents

Bando's latest patents include an alkylating agent specifically designed to target genetic mutations in driver oncogenes. This invention provides a complex formed by binding an alkylating agent to a pyrrole imidazole polyamide, which specifically binds to the mutation site of a driver oncogene. Additionally, he has developed a CTB-PI polyamide conjugate that acts as a histone modification control agent, activating the expression of specific genes related to stem cell maintenance and differentiation.

Career Highlights

Throughout his career, Toshikazu Bando has worked with notable institutions, including Kyoto University. His research has focused on innovative solutions in the field of genetic engineering and cancer therapeutics. His contributions have been recognized within the scientific community, and he continues to push the boundaries of biotechnology.

Collaborations

Bando has collaborated with esteemed colleagues such as Hiroshi Sugiyama and Hiroki Nagase. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Toshikazu Bando's innovative work in biotechnology exemplifies the potential of scientific research to address critical health challenges. His patents and collaborations reflect a commitment to advancing knowledge and technology in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…